title: Response to Parikh.
authors.affiliation: From the Department of Psychiatry, University of California, Los Angeles School of Medicine, Los Angeles (Dr. Miklowitz); the Department of Psychiatry, University of Colorado Health Sciences Center, Denver (Dr. Schneck); the Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh (Dr. Birmaher); the Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati (Dr. Delbello); and the Department of Psychiatry, The Ohio State University and Nationwide Children's Hospital, Columbus, Ohio (Dr. Axelson).
authors.forename: David J
authors.initials: DJ
authors.lastname: Miklowitz
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Schneck
authors.forename: Boris
authors.initials: B
authors.lastname: Birmaher
authors.forename: Melissa P
authors.initials: MP
authors.lastname: Delbello
authors.forename: David A
authors.initials: DA
authors.lastname: Axelson
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000628:therapy*; D005196:Family Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D014150:Antipsychotic Agents